These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33278954)

  • 1. Targeted clindamycin delivery to pilosebaceous units by chitosan or hyaluronic acid nanoparticles for improved topical treatment of acne vulgaris.
    Tolentino S; Pereira MN; Cunha-Filho M; Gratieri T; Gelfuso GM
    Carbohydr Polym; 2021 Feb; 253():117295. PubMed ID: 33278954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid-modified betamethasone encapsulated polymeric nanoparticles: fabrication, characterisation, in vitro release kinetics, and dermal targeting.
    Pandey M; Choudhury H; Gunasegaran TAP; Nathan SS; Md S; Gorain B; Tripathy M; Hussain Z
    Drug Deliv Transl Res; 2019 Apr; 9(2):520-533. PubMed ID: 29488170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of liposome encapsulated clindamycin for treatment of acne vulgaris.
    Honzak L; Sentjurc M
    Pflugers Arch; 2000; 440(5 Suppl):R44-5. PubMed ID: 11005607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel vesicular and particulate drug delivery systems for topical treatment of acne.
    Castro GA; Ferreira LA
    Expert Opin Drug Deliv; 2008 Jun; 5(6):665-79. PubMed ID: 18532922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical clindamycin in the management of acne vulgaris.
    Guay DR
    Expert Opin Pharmacother; 2007 Oct; 8(15):2625-64. PubMed ID: 17931096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris.
    Khodaeiani E; Fouladi RF; Amirnia M; Saeidi M; Karimi ER
    Int J Dermatol; 2013 Aug; 52(8):999-1004. PubMed ID: 23786503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarriers as versatile delivery systems for effective management of acne.
    Patel R; Prabhu P
    Int J Pharm; 2020 Apr; 579():119140. PubMed ID: 32061843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical Nano-emulgel for Skin Disorders: Formulation Approach and Characterization.
    Ahmad J; Gautam A; Komath S; Bano M; Garg A; Jain K
    Recent Pat Antiinfect Drug Discov; 2019; 14(1):36-48. PubMed ID: 30488798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intradermal and follicular delivery of adapalene liposomes.
    Kumar V; Banga AK
    Drug Dev Ind Pharm; 2016; 42(6):871-9. PubMed ID: 27031916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
    Kellett N; West F; Finlay AY
    Br J Dermatol; 2006 Mar; 154(3):524-32. PubMed ID: 16445786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single centre, open-label, cross-over study of pharmacokinetics comparing topical zinc/clindamycin gel (Zindaclin) and topical clindamycin lotion (Dalacin T) in subjects with mild to moderate acne.
    Chassard D; Kanis R; Namour F; Evene E; Ntssikoussalabongui B; Schmitz V
    J Dermatolog Treat; 2006; 17(3):154-7. PubMed ID: 16854755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal absorption of topical anti-acne agents in man; review of clinical pharmacokinetic data.
    van Hoogdalem EJ
    J Eur Acad Dermatol Venereol; 1998 Sep; 11 Suppl 1():S13-9; discussion S28-9. PubMed ID: 9891904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris.
    Jurairattanaporn N; Chalermchai T; Ophaswongse S; Udompataikul M
    J Med Assoc Thai; 2017 Jan; 100(1):78-85. PubMed ID: 29911775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris.
    Del Rosso JQ; Schmidt NF
    Cutis; 2010 Jan; 85(1):15-24. PubMed ID: 20184207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of an Inflammation-Sensitive Polyelectrolyte-Based Topical Drug Delivery System for Arthritis.
    Bijukumar D; Choonara YE; Murugan K; Choonara BF; Kumar P; du Toit LC; Pillay V
    AAPS PharmSciTech; 2016 Oct; 17(5):1075-85. PubMed ID: 26515798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
    Kalam MA
    Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44.
    Wang T; Hou J; Su C; Zhao L; Shi Y
    J Nanobiotechnology; 2017 Jan; 15(1):7. PubMed ID: 28068992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
    Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
    Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
    Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
    Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
    Cunliffe WJ; Holland KT; Bojar R; Levy SF
    Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.